| Lorcaserin Hydrochloride | EISAI INC | ||
| 10 mg; Tablet, Oral |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
Less Than 5
|
||
| None | None | ||
| An adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. | |||
|
Yes
| |||
| Belviq | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ***** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ********* | **** *** | **** *** | **** *** | ******* | **** *** | **** *** | **** *** | **** *** | **** *** | ******* | **** *** | ******* | ******* | ******* | ******* |
| ***** ****** | **** *** | **** *** | **** *** | *** ********* | **** *** | **** *** | **** *** | **** *** | **** *** | *** ********* | **** *** | *** ********* | *** ********* | *** ********* | *** ********* (***** ******) |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | *** \ ** | ***** **, **** | ******* | **** | ******* **** **** *** *** **** |
| ********* | ** \ ** | *** *, **** | ******* | ********* ******** | ******* **** **** *** *** **** |
| ***** ****** | ** \ ** | -**- | *** ********* | ********* ******** | ** *** **, **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|